Search - tctmd.com

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

Advertisement

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Stroke After STEMI Unusual But Carries Poor Prognosis

ESC Offers Recommendations on Use of New Oral Anticoagulants

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Danish Registry: Dabigatran Safe, Effective in Real-World Use

No Survival Difference Between One-Time, Staged PCI for Patients Without STEMI

DEFER-STEMI: Holding Off Stenting for Several Hours Improves Outcomes

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Evidence Continues to Support Dabigatran Treatment in A-fib

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content